Skip to main content

Table 4 Associations between vertebral fracture and lung function according to fracture site

From: Cross-sectional associations between prevalent vertebral fracture and pulmonary function in the sixth Tromsø study

 

Pulmonary function (mean (SD) or (SE))

 

Men

Women

 

No vertebral fracture (n = 771)

Fracture T4-T12 (n = 82)

Fracture L1-L4 (n = 39)

P T4-T12a

P L1-L4a

No vertebral fracture (n = 1079)

Fracture T4-T12 (n = 94)

Fracture L1-L4 (n = 67)

P T4-T12a

P L1-L4a

FVC% predictedb

98.2 (15.3)

97.0 (17.5)

97.7 (18.1)

0.500

0.856

101.2 (15.8)

104.4 (17.4)

99.0 (18.7)

0.058

0.264

FEV1% predictedb

88.9 (16.9)

85.7 (21.4)

85.3 (21.5)

0.120

0.219

93.0 (17.4)

95.8 (19.5)

89.8 (22.3)

0.145

0.154

FEV1/FVC% predicteda

90.6 (10.8)

87.8 (13.6)

86.8 (11.8)

0.027

0.035

92.0 (9.1)

91.3 (9.6)

89.6 (11.4)

0.505

0.046

Adjustedc values

(n = 665)

(n = 74)

(n = 31)

  

(n = 800)

(n = 60)

(n = 44)

  

FVC (liter (SE))

4.22 (0.024)

4.18 (0.073)

4.34 (0.113)

0.569

0.296

2.99 (0.015)

3.10 (0.055)

2.89 (0.066)

0.045

0.141

FEV1 (liter (SE))

3.08 (0.021)

3.01 (0.063)

3.16 (0.098)

0.292

0.415

2.21 (0.013)

2.32 (0.048)

2.14 (0.057)

0.032

0.212

FEV1/FVC (SE)

0.73 (0.003)

0.72 (0.009)

0.73 (0.014)

0.240

0.857

0.74 (0.002)

0.75 (0.008)

0.74 (0.010)

0.405

0.960

  1. The Tromsø Study 2007-08.
  2. aVersus no fracture.
  3. bEquation from Langhammer et al. [27].
  4. cAdjusted for age, smoking habits, height, weight, physical inactivity, cardiovascular disease, lung disease, corticosteroids, hip BMD, hormones for menopause (women).